These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 10551545)
1. Genetic association between cytochrome P-450 2D6 gene polymorphism and plasma concentration of haloperidol in Japanese schizophrenics. Shibata N; Ohnuma T; Baba H; Shimada H; Takahashi T; Arai H Psychiatr Genet; 1999 Sep; 9(3):145-8. PubMed ID: 10551545 [TBL] [Abstract][Full Text] [Related]
2. Haloperidol plasma concentration in Japanese psychiatric subjects with gene duplication of CYP2D6. Ohnuma T; Shibata N; Matsubara Y; Arai H Br J Clin Pharmacol; 2003 Sep; 56(3):315-20. PubMed ID: 12919180 [TBL] [Abstract][Full Text] [Related]
3. Effect of a genetic polymorphism of CYP1A2 inducibility on the steady state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia. Mihara K; Suzuki A; Kondo T; Yasui N; Furukori H; Nagashima U; Ono S; Kaneko S; Otani K; Inoue Y Ther Drug Monit; 2000 Jun; 22(3):245-9. PubMed ID: 10850389 [TBL] [Abstract][Full Text] [Related]
4. Lack of correlation between the steady-state plasma concentrations of aripiprazole and haloperidol in Japanese patients with schizophrenia. Nakamura A; Mihara K; Nemoto K; Nagai G; Kagawa S; Suzuki T; Kondo T Ther Drug Monit; 2014 Dec; 36(6):815-8. PubMed ID: 24739668 [TBL] [Abstract][Full Text] [Related]
5. Depot haloperidol treatment in outpatients with schizophrenia on monotherapy: impact of CYP2D6 polymorphism on pharmacokinetics and treatment outcome. Panagiotidis G; Arthur HW; Lindh JD; Dahl ML; Sjöqvist F Ther Drug Monit; 2007 Aug; 29(4):417-22. PubMed ID: 17667795 [TBL] [Abstract][Full Text] [Related]
6. Effects of the CYP2D6*10 allele on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia. Mihara K; Suzuki A; Kondo T; Yasui N; Furukori H; Nagashima U; Otani K; Kaneko S; Inoue Y Clin Pharmacol Ther; 1999 Mar; 65(3):291-4. PubMed ID: 10096261 [TBL] [Abstract][Full Text] [Related]
7. The effect of cytochrome P450 2D6 genotypes on haloperidol metabolism: a preliminary study in a psychiatric population. Someya T; Suzuki Y; Shimoda K; Hirokane G; Morita S; Yokono A; Inoue Y; Takahashi S Psychiatry Clin Neurosci; 1999 Oct; 53(5):593-7. PubMed ID: 10595685 [TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 2D6 genotyping and association with tardive dyskinesia in Chinese schizophrenic patients. Lam LC; Garcia-Barcelo MM; Ungvari GS; Tang WK; Lam VK; Kwong SL; Lau BS; Kwong PP; Waye MM; Chiu HF Pharmacopsychiatry; 2001 Nov; 34(6):238-41. PubMed ID: 11778144 [TBL] [Abstract][Full Text] [Related]
9. Effects of the CYP2D6 genotype on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese schizophrenic patients. Suzuki A; Otani K; Mihara K; Yasui N; Kaneko S; Inoue Y; Hayashi K Pharmacogenetics; 1997 Oct; 7(5):415-8. PubMed ID: 9352580 [No Abstract] [Full Text] [Related]
10. Importance of the cytochrome P450 2D6 genotype for the drug metabolic interaction between chlorpromazine and haloperidol. Suzuki Y; Someya T; Shimoda K; Hirokane G; Morita S; Yokono A; Inoue Y; Takahashi S Ther Drug Monit; 2001 Aug; 23(4):363-8. PubMed ID: 11477317 [TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patients. Roh HK; Chung JY; Oh DY; Park CS; Svensson JO; Dahl ML; Bertilsson L Br J Clin Pharmacol; 2001 Sep; 52(3):265-71. PubMed ID: 11560558 [TBL] [Abstract][Full Text] [Related]
12. [Cytochrome P450*2D6 gene polymorphism in Chinese population]. Tao E; Liu Z; Chen B; Pan X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Feb; 15(1):34-7. PubMed ID: 9456373 [TBL] [Abstract][Full Text] [Related]
13. The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients. van der Weide K; van der Weide J J Clin Psychopharmacol; 2015 Jun; 35(3):228-36. PubMed ID: 25868121 [TBL] [Abstract][Full Text] [Related]
14. CYP2D6*10 alleles are not the determinant of the plasma haloperidol concentrations in Asian patients. Shimoda K; Morita S; Yokono A; Someya T; Hirokane G; Sunahara N; Takahashi S Ther Drug Monit; 2000 Aug; 22(4):392-6. PubMed ID: 10942177 [TBL] [Abstract][Full Text] [Related]
15. Effects of smoking and cytochrome P450 2D6*10 allele on the plasma haloperidol concentration/dose ratio. Ohara K; Tanabu S; Yoshida K; Ishibashi K; Ikemoto K; Shibuya H Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):945-9. PubMed ID: 14499311 [TBL] [Abstract][Full Text] [Related]
16. [Effect of factors on plasma haloperidol concentration/dose ratio]. Ohara K; Shibuya H Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Aug; 23(4):183-6. PubMed ID: 13677914 [TBL] [Abstract][Full Text] [Related]
17. Lack of impact of CYP1A2 genetic polymorphism (C/A polymorphism at position 734 in intron 1 and G/A polymorphism at position -2964 in the 5'-flanking region of CYP1A2) on the plasma concentration of haloperidol in smoking male Japanese with schizophrenia. Shimoda K; Someya T; Morita S; Hirokane G; Yokono A; Takahashi S; Okawa M Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):261-5. PubMed ID: 11817502 [TBL] [Abstract][Full Text] [Related]
18. The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment. Brockmöller J; Kirchheiner J; Schmider J; Walter S; Sachse C; Müller-Oerlinghausen B; Roots I Clin Pharmacol Ther; 2002 Oct; 72(4):438-52. PubMed ID: 12386646 [TBL] [Abstract][Full Text] [Related]
19. Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of dopamine D2 receptor and cytochrome P450 2D6 in Japanese patients with schizophrenia. Nagai G; Mihara K; Nakamura A; Suzuki T; Nemoto K; Kagawa S; Ohta I; Arakaki H; Kondo T Psychiatry Clin Neurosci; 2012 Oct; 66(6):518-24. PubMed ID: 23066770 [TBL] [Abstract][Full Text] [Related]
20. CYP2D6 polymorphism: implications for antipsychotic drug response, schizophrenia and personality traits. Dorado P; Peñas-Lledó EM; Llerena A Pharmacogenomics; 2007 Nov; 8(11):1597-608. PubMed ID: 18034624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]